#	Pagina
attuale pagina	/open-h2020/projects/221023/index.html
-1	/open-h2020/projects/218661/index.html
-2	/open-h2020/per-topic/roots/list/index.html
-3	/open-h2020/projects/199415/index.html
-4	/open-h2020/per-topic/out/list/index.html
-5	/open-h2020/per-topic/hula/list/index.html
-6	/open-h2020/per-topic/geolake/list/index.html
-7	/open-h2020/projects/196425/results.html
-8	/open-h2020/per-topic/airline/list/index.html

Opendata, web and dolomites

BioMensio SIGNED

BioMensio mobile biosensing platform: the first truly palm-sized and accurate digital multi-drug test

Total Cost €

EC-Contrib. €

Partnership

Views

BioMensio project word cloud

Explore the words cloud of the BioMensio project. It provides you a very rough idea of what is the project "BioMensio" about.

mechanism device virtually rapid suited variety palm solutions deaths sized helps simultaneously legalisation instrumentation employers influence paramedics levels ready globally narcotics fuelled performance finland fatalities uncertain first saliva hampered preventative bulkiness machinery drivers injuries off worldwide deploying deployment traffic surpassed accuracy biomensio detect accelerator accurate bio centre stage driving tools drugs backed mass administrate prevent exceeds illicit market intoxication reduce understand alcohol company found patient vtt mishandling government war inability accidents people fatal coming heavy designed drive billion person spin drugged platform caused provides proof norms police efficient minutes drug million siemens patented stringent sensing workplace

Project "BioMensio" data sheet

The following table provides information about the project.

Coordinator	BIOMENSIO OY Organization address address: HERMIANKATU 6-8 H city: TAMPERE postcode: 33720 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.
Coordinator Country	Finland [FI]
Total cost	3˙560˙030 €
EC max contribution	2˙492˙021 € (70%)
Programme	1. H2020-EU.3. (PRIORITY 'Societal challenges) 2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs) 3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
Code Call	H2020-SMEInst-2018-2020-2
Funding Scheme	SME-2
Starting year	2019
Duration (year-month-day)	from 2019-03-01 to 2021-02-28

Partnership

Take a look of project's partnership.

#	participants	country	role	EC contrib. [€]
1	BIOMENSIO OY BIOMENSIO OY Organization address address: HERMIANKATU 6-8 H city: TAMPERE postcode: 33720 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	FI (TAMPERE)	coordinator	2˙492˙021.00

Map

Project objective

In the EU, well over 8 million people have been found to drive under the influence of illicit drugs. In the US, fatal traffic accidents caused by drugged driving has already surpassed alcohol-induced traffic deaths. Drug intoxication testing is an efficient mechanism that helps to avoid drug related fatalities, such as traffic accidents or heavy machinery mishandling. However, the current testing solutions are not suited for wide scale deployment and thus cannot make a meaningful impact in the war against drugs. They are hampered by the bulkiness and high cost of instrumentation, uncertain levels of accuracy, and inability to detect the growing variety of drugs.

BioMensio multi-drug testing platform is the first palm-sized and highly accurate device to detect drug intoxication from saliva, designed specifically for the police to detect drugged drivers, paramedics to better understand patient condition, and employers to prevent workplace injuries. Our patented bio-sensing technology enables to simultaneously measure a person’s intoxication from virtually any widely used narcotics, in an easy-to-administrate test that provides results in just 1-2 minutes. This by far exceeds the performance of any other current or up-and-coming technology.

BioMensio is a spin-off company from Siemens Technology Accelerator and VTT Technical Research Centre of Finland, and has been backed with €3.5 million early stage funding. We are now beyond the proof-of-concept phase and are ready to scale our technology. We target the globally growing €1 billion saliva-based rapid drug testing market, which is fuelled by increasingly stringent government norms and workplace drug testing legalisation worldwide. As the key to reduce drug related fatalities and injuries is widely deploying and applying preventative tools, the main goal of our project is bring our patented bio-sensing platform to the mass market.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "BIOMENSIO" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "BIOMENSIO" are provided by the European Opendata Portal: CORDIS opendata.